Prostate Cancer Clinical Trial
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
Summary
Observational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer patients and to evaluate the risk of developing second primary cancers.
Eligibility Criteria
Inclusion Criteria:
Treatment decision to Radium-223 needs to be made independent from and before patient enrollment in the study
Histologically or cytologically confirmed castration resistant adenocarcinoma of the prostate with bone metastases
Signed informed consent
Exclusion Criteria:
Previously treated with Radium-223 for any reason
Currently treated in clinical trials including other Radium-223 studies
Planned for the systemic concomitant use of other radiopharmaceuticals for treatment of prostate cancer or for other use
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Homewood Alabama, , United States
Anchorage Alaska, , United States
Scottsdale Arizona, , United States
Daly City California, , United States
Long Beach California, , United States
Sacramento California, , United States
San Diego California, , United States
Colorado Springs Colorado, , United States
Boca Raton Florida, , United States
Fort Myers Florida, , United States
Jacksonville Florida, , United States
Lakewood Ranch Florida, , United States
Plantation Florida, , United States
Atlanta Georgia, , United States
Decatur Georgia, , United States
Honolulu Hawaii, , United States
Evanston Illinois, , United States
Maywood Illinois, , United States
Urbana Illinois, , United States
Warrenville Illinois, , United States
Wichita Kansas, , United States
Ashland Kentucky, , United States
New Orleans Louisiana, , United States
Baltimore Maryland, , United States
Rockville Maryland, , United States
Towson Maryland, , United States
Boston Massachusetts, , United States
Troy Michigan, , United States
Saint Louis Missouri, , United States
Billings Montana, , United States
Omaha Nebraska, , United States
Lebanon New Hampshire, , United States
Neptune New Jersey, , United States
Township New Jersey, , United States
Buffalo New York, , United States
East Setauket New York, , United States
Lake Success New York, , United States
Syracuse New York, , United States
Winston-Salem North Carolina, , United States
Middleburg Heights Ohio, , United States
Oklahoma City Oklahoma, , United States
Springfield Oregon, , United States
Abington Pennsylvania, , United States
Charleston South Carolina, , United States
Myrtle Beach South Carolina, , United States
Nashville Tennessee, , United States
Houston Texas, , United States
Lubbock Texas, , United States
San Antonio Texas, , United States
Temple Texas, , United States
Charlottesville Virginia, , United States
Virginia Beach Virginia, , United States
Seattle Washington, , United States
Multiple Locations , , Argentina
Multiple Locations , , Austria
Multiple Locations , , Belgium
Multiple Locations , , Canada
Multiple Locations , , Colombia
Multiple Locations , , Czechia
Multiple Locations , , Denmark
Multiple Locations , , France
Multiple Locations , , Germany
Multiple Locations , , Greece
Multiple Locations , , Israel
Multiple Locations , , Italy
Multiple Locations , , Luxembourg
Multiple Locations , , Mexico
Multiple Locations , , Netherlands
Multiple Locations , , Portugal
Multiple Locations , , Spain
Multiple Locations , , Sweden
Multiple Locations , , United Kingdom
How clear is this clinincal trial information?